TR200003567T2 - Östrojen reseptörü ayarlayıcısını ve paratiroid hormonu içeren kombinasyonlar - Google Patents

Östrojen reseptörü ayarlayıcısını ve paratiroid hormonu içeren kombinasyonlar

Info

Publication number
TR200003567T2
TR200003567T2 TR2000/03567T TR200003567T TR200003567T2 TR 200003567 T2 TR200003567 T2 TR 200003567T2 TR 2000/03567 T TR2000/03567 T TR 2000/03567T TR 200003567 T TR200003567 T TR 200003567T TR 200003567 T2 TR200003567 T2 TR 200003567T2
Authority
TR
Turkey
Prior art keywords
compositions
parathyroid hormone
adjuster
estrogen receptor
combinations containing
Prior art date
Application number
TR2000/03567T
Other languages
English (en)
Inventor
Zhu Ke Hua
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200003567T2 publication Critical patent/TR200003567T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Bu bulus (-)-cis-6-fenil-5- (4-(2-pirrolidin-1-il-etoksi)-fenil) -5,6,7,8-tetrahidronaftalen-2-ol ya da bunun farmasötik olarak uygun olan bir tuzunu ve paratiroid hormonu ya da bunun biyolojik olarak aktif olan bir kismini içeren farmasötik bilesik kompozisyonlari ve yöntemleri ile, bu gibi kompozisyonlari içeren kompozisyonlarin ve kitlerin kullanildigi yöntemler ile ilgilidir. Kompozisyonlar osteoporozis yani kemik erimesini, osteoporotik yani kemik erimesine bagli kirilmayi, kemik kütlesinin azalmasini ve kiriklari kapsayan kas iskelet sistemi kiriklarinin tedavisinde yararlidir.
TR2000/03567T 1998-06-16 1999-05-26 Östrojen reseptörü ayarlayıcısını ve paratiroid hormonu içeren kombinasyonlar TR200003567T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
TR200003567T2 true TR200003567T2 (tr) 2001-06-21

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03567T TR200003567T2 (tr) 1998-06-16 1999-05-26 Östrojen reseptörü ayarlayıcısını ve paratiroid hormonu içeren kombinasyonlar

Country Status (34)

Country Link
US (1) US6132774A (tr)
EP (1) EP1094808A1 (tr)
JP (1) JP2002518323A (tr)
KR (1) KR20010052818A (tr)
CN (1) CN1305373A (tr)
AP (1) AP9901580A0 (tr)
AR (1) AR018867A1 (tr)
AU (1) AU3725999A (tr)
BG (1) BG105125A (tr)
BR (1) BR9911228A (tr)
CA (1) CA2335078A1 (tr)
CO (1) CO5070584A1 (tr)
EA (1) EA200001199A1 (tr)
GT (1) GT199900066A (tr)
HN (1) HN1999000063A (tr)
HR (1) HRP20000858A2 (tr)
HU (1) HUP0102759A3 (tr)
ID (1) ID26873A (tr)
IL (1) IL139588A0 (tr)
IS (1) IS5719A (tr)
MA (1) MA26649A1 (tr)
NO (1) NO20006313L (tr)
NZ (1) NZ508039A (tr)
OA (1) OA11566A (tr)
PA (1) PA8471201A1 (tr)
PE (1) PE20000644A1 (tr)
PL (1) PL344982A1 (tr)
SK (1) SK18922000A3 (tr)
TN (1) TNSN99119A1 (tr)
TR (1) TR200003567T2 (tr)
UA (1) UA60367C2 (tr)
WO (1) WO1999065482A1 (tr)
YU (1) YU75800A (tr)
ZA (1) ZA993972B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
RU2422450C2 (ru) 2003-11-19 2011-06-27 Метабазис Терапеутикс, Инк. Новые фосфорсодержащие тиромиметики
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
NZ508039A (en) 2003-03-28
AU3725999A (en) 2000-01-05
AR018867A1 (es) 2001-12-12
YU75800A (sh) 2003-12-31
ZA993972B (en) 2000-12-15
PE20000644A1 (es) 2000-08-02
ID26873A (id) 2001-02-15
IS5719A (is) 2000-11-21
MA26649A1 (fr) 2004-12-20
HUP0102759A3 (en) 2002-12-28
BR9911228A (pt) 2001-02-13
CA2335078A1 (en) 1999-12-23
SK18922000A3 (sk) 2001-09-11
CO5070584A1 (es) 2001-08-28
HRP20000858A2 (en) 2001-10-31
EP1094808A1 (en) 2001-05-02
GT199900066A (es) 2000-10-31
TNSN99119A1 (fr) 2005-11-10
PL344982A1 (en) 2001-11-19
PA8471201A1 (es) 2000-09-29
NO20006313D0 (no) 2000-12-12
JP2002518323A (ja) 2002-06-25
US6132774A (en) 2000-10-17
HN1999000063A (es) 2000-01-12
OA11566A (en) 2004-05-26
NO20006313L (no) 2000-12-12
HUP0102759A2 (hu) 2002-03-28
KR20010052818A (ko) 2001-06-25
AP9901580A0 (en) 1999-06-30
WO1999065482A1 (en) 1999-12-23
IL139588A0 (en) 2002-02-10
BG105125A (en) 2001-11-30
EA200001199A1 (ru) 2001-04-23
CN1305373A (zh) 2001-07-25
UA60367C2 (uk) 2003-10-15

Similar Documents

Publication Publication Date Title
TR200003567T2 (tr) Östrojen reseptörü ayarlayıcısını ve paratiroid hormonu içeren kombinasyonlar
TR200003455T2 (tr) Kemik dayanıklılığını ve sertliğini arttırmak ve kırıkları azaltmak için yöntem
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
SG148037A1 (en) Fgf variants and methods for use thereof
AP9801269A0 (en) Prostaglandin agonists.
YU7797A (sh) Kombinovana terapija za osteoporozu
FR06C0032I1 (tr)
MY129150A (en) Novel sulfamides
DE69811933D1 (de) Wirbelsäulenimplantat
CA2337991A1 (en) Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
UA50808C2 (uk) Композиція для лікування респіраторного дистрес-синдрому дорослих або респіраторного дистрес-синдрому новонароджених
ATE443527T1 (de) 5-cnac zur oralen verabreichung von parathormonfragmenten
BR9912223A (pt) Agente terapêutico para crise hipercalcêmica
PH30665A (en) Aminosulfonyl urea acat inhibitors
MY159417A (en) Calcilytic compounds
AU6399498A (en) Fracture nail for intramedullary nailing of long shaft bones
CA2274381A1 (en) Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin e2
IT1292013B1 (it) Chiodo endomidollare per la riduzione di fratture ossee
EP1769804A3 (en) Method of increasing bone toughness and stiffness and reducing fractures
GB9709338D0 (en) An Intramedullary nail for treatment of four-part and other fractures of the surgical neck and shaft of the humerus